Micron (MU) Stock Gains as Analysts Back Strong Memory Outlook
TLDR Micron stock opened 4.72% higher, outperforming the Technology Equipment sector’s 2.37% gain. Strong AI server demand is supp...
Applied Materials (AMAT) Earnings Preview: What to Expect Thursday After Market...
Applied Materials (AMAT) reports Q3 earnings Thursday. Analysts expect $9B revenue, up 23% YoY, and EPS of $3.39. Stock could move...
July Inflation Data Meets Forecasts: Markets Rally on Fed Rate Pause Hopes
Stock markets rallied after July CPI matched expectations at 3.4%. Tech stocks led gains while traders now favor a Fed rate hold i...
Aptevo Therapeutics Inc. (APVO) Stock: New Financing Targets $4.5M in Gross Proc...
TLDR Aptevo targets $4.5 million through warrant exercises and a private placement. Existing warrant holders will exercise up to 2...
Dell Technologies Inc. (DELL) Stock Surges as AI Demand Fuels Fresh Momentum
TLDR DELL stock gained 4.88%, outperforming the Technology Equipment sector’s 2.48% rise. AI server demand supported Dell shares,...
Piper Sandler Sets $38 Target on Unusual Machines (UMAC) Stock, Forecasts $103M...
Piper Sandler initiates Unusual Machines (UMAC) at Overweight with $38 target, projecting revenue growth to $103M by 2027 on Penta...
Michael Burry Compares Nvidia (NVDA) $500B AI Deal to 2008 Financial Crisis Tact...
Michael Burry criticizes Nvidia's $500B AI financing arrangement with major asset managers, warning of risks similar to those befo...
Nebius (NBIS) Stock Rallies on Q2 Beat—What Comes Next?
TLDR Nebius stock surged about 18% after the company reported stronger-than-expected second-quarter results. Revenue climbed 454%...
Super Micro Computer (SMCI) Stock Soars 14% as Analysts Boost Targets on Stellar...
SMCI stock jumped 14% after beating Q4 earnings and issuing FY2027 revenue guidance up to $72B. Analysts from Bernstein, Needham r...
Eli Lilly (LLY) Targets Black-Market Sales of Unapproved Weight-Loss Drug in Leg...
Eli Lilly (LLY) initiates lawsuits against six companies over illegal sales of retatrutide, an experimental obesity treatment not...